 Angela Pierce
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor Protein-Tyrosine Kinases | 5 | 2016 | 227 | 1.190 |
Why?
| | Brain Neoplasms | 4 | 2020 | 984 | 0.760 |
Why?
| | Glioblastoma | 4 | 2016 | 253 | 0.700 |
Why?
| | Cerebellar Neoplasms | 4 | 2023 | 130 | 0.700 |
Why?
| | Medulloblastoma | 4 | 2023 | 172 | 0.680 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2019 | 67 | 0.670 |
Why?
| | Infratentorial Neoplasms | 1 | 2019 | 46 | 0.660 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 190 | 0.620 |
Why?
| | Reproduction | 2 | 2011 | 181 | 0.610 |
Why?
| | Ependymoma | 1 | 2019 | 156 | 0.590 |
Why?
| | Proto-Oncogene Proteins | 6 | 2022 | 610 | 0.590 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2020 | 398 | 0.490 |
Why?
| | Transplantation, Heterologous | 1 | 2014 | 183 | 0.460 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 232 | 0.460 |
Why?
| | Carcinogenesis | 1 | 2013 | 180 | 0.400 |
Why?
| | Central Nervous System | 1 | 2013 | 237 | 0.390 |
Why?
| | Estrous Cycle | 1 | 2011 | 14 | 0.380 |
Why?
| | Cell Line, Tumor | 12 | 2023 | 2725 | 0.370 |
Why?
| | Gonadotropin-Releasing Hormone | 2 | 2011 | 188 | 0.370 |
Why?
| | Pituitary Gland | 1 | 2011 | 148 | 0.350 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3542 | 0.350 |
Why?
| | Hypothalamus | 1 | 2011 | 147 | 0.350 |
Why?
| | Ovary | 1 | 2011 | 191 | 0.330 |
Why?
| | Rhabdoid Tumor | 2 | 2022 | 80 | 0.330 |
Why?
| | Glioma | 3 | 2022 | 294 | 0.330 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 552 | 0.320 |
Why?
| | Oncogene Proteins | 1 | 2008 | 53 | 0.310 |
Why?
| | Neurons | 3 | 2014 | 1281 | 0.300 |
Why?
| | Cell Proliferation | 7 | 2022 | 2196 | 0.260 |
Why?
| | Apoptosis | 5 | 2022 | 2369 | 0.230 |
Why?
| | Mice | 11 | 2022 | 14916 | 0.230 |
Why?
| | Antineoplastic Agents | 4 | 2022 | 1895 | 0.220 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 706 | 0.200 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2016 | 350 | 0.200 |
Why?
| | CDC2 Protein Kinase | 1 | 2002 | 25 | 0.200 |
Why?
| | Animals | 14 | 2022 | 31762 | 0.200 |
Why?
| | DNA, Fungal | 1 | 2002 | 69 | 0.200 |
Why?
| | Teratoma | 2 | 2022 | 92 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 56 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2021 | 115 | 0.190 |
Why?
| | Radiation Tolerance | 1 | 2022 | 92 | 0.190 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2020 | 1147 | 0.180 |
Why?
| | DNA Replication | 1 | 2002 | 205 | 0.180 |
Why?
| | Pyrazoles | 2 | 2022 | 364 | 0.180 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 40 | 0.180 |
Why?
| | Genes, myc | 1 | 2020 | 47 | 0.170 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 32 | 0.170 |
Why?
| | Protein Kinase Inhibitors | 2 | 2016 | 795 | 0.170 |
Why?
| | DNA Repair | 1 | 2021 | 186 | 0.170 |
Why?
| | Mice, Nude | 3 | 2019 | 635 | 0.170 |
Why?
| | Pyrimidinones | 1 | 2020 | 88 | 0.170 |
Why?
| | Deoxycytidine | 1 | 2020 | 138 | 0.160 |
Why?
| | SMARCB1 Protein | 1 | 2019 | 17 | 0.160 |
Why?
| | Cellular Senescence | 2 | 2019 | 152 | 0.160 |
Why?
| | Mice, SCID | 1 | 2019 | 320 | 0.160 |
Why?
| | DNA-Binding Proteins | 2 | 2004 | 1314 | 0.160 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2002 | 333 | 0.160 |
Why?
| | Piperazines | 2 | 2022 | 311 | 0.160 |
Why?
| | Histones | 2 | 2020 | 536 | 0.160 |
Why?
| | c-Mer Tyrosine Kinase | 3 | 2016 | 43 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 1 | 2002 | 477 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 447 | 0.150 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 854 | 0.150 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 561 | 0.150 |
Why?
| | Polyploidy | 1 | 2016 | 17 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2019 | 312 | 0.140 |
Why?
| | Mice, Knockout | 3 | 2014 | 2582 | 0.130 |
Why?
| | Survival Rate | 1 | 2019 | 1642 | 0.130 |
Why?
| | Cell Death | 1 | 2016 | 322 | 0.120 |
Why?
| | Adenine | 1 | 2016 | 219 | 0.120 |
Why?
| | Nuclear Proteins | 3 | 2023 | 592 | 0.120 |
Why?
| | Pentacyclic Triterpenes | 1 | 2014 | 13 | 0.120 |
Why?
| | Sexual Maturation | 1 | 2014 | 47 | 0.120 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 91 | 0.110 |
Why?
| | Anilides | 1 | 2014 | 67 | 0.110 |
Why?
| | Quinolines | 1 | 2014 | 129 | 0.110 |
Why?
| | Vagina | 1 | 2014 | 146 | 0.100 |
Why?
| | Humans | 16 | 2023 | 114757 | 0.100 |
Why?
| | Cell Movement | 3 | 2014 | 867 | 0.100 |
Why?
| | Chromatin | 3 | 2020 | 428 | 0.100 |
Why?
| | Superovulation | 1 | 2011 | 8 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2011 | 14 | 0.090 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 75 | 0.090 |
Why?
| | Feedback, Physiological | 1 | 2011 | 68 | 0.090 |
Why?
| | Chorionic Gonadotropin | 1 | 2011 | 78 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2014 | 543 | 0.090 |
Why?
| | Ovariectomy | 1 | 2011 | 116 | 0.090 |
Why?
| | Aging | 1 | 2020 | 1620 | 0.090 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 4710 | 0.090 |
Why?
| | Cell Cycle | 2 | 2004 | 543 | 0.090 |
Why?
| | Luteinizing Hormone | 1 | 2011 | 169 | 0.090 |
Why?
| | Follicle Stimulating Hormone | 1 | 2011 | 216 | 0.090 |
Why?
| | Child | 4 | 2023 | 18352 | 0.090 |
Why?
| | Cell Survival | 2 | 2014 | 1021 | 0.080 |
Why?
| | Epigenomics | 2 | 2020 | 102 | 0.080 |
Why?
| | Periodontal Ligament | 1 | 2009 | 2 | 0.080 |
Why?
| | Tooth Movement Techniques | 1 | 2009 | 11 | 0.080 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2009 | 15 | 0.080 |
Why?
| | Nerve Growth Factor | 1 | 2009 | 27 | 0.080 |
Why?
| | Estrus | 1 | 2008 | 11 | 0.080 |
Why?
| | Prosencephalon | 1 | 2008 | 45 | 0.080 |
Why?
| | Female | 7 | 2020 | 59507 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2008 | 159 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 514 | 0.070 |
Why?
| | Models, Neurological | 1 | 2008 | 212 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 863 | 0.070 |
Why?
| | Nerve Net | 1 | 2008 | 226 | 0.060 |
Why?
| | Base Sequence | 1 | 2008 | 2118 | 0.060 |
Why?
| | Signal Transduction | 2 | 2014 | 4522 | 0.060 |
Why?
| | Tyrosine | 1 | 2023 | 215 | 0.050 |
Why?
| | Cell Line | 1 | 2008 | 2639 | 0.050 |
Why?
| | Male | 5 | 2020 | 55579 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 147 | 0.050 |
Why?
| | Cyclin B | 1 | 2002 | 13 | 0.050 |
Why?
| | Replication Origin | 1 | 2002 | 15 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 41 | 0.050 |
Why?
| | S Phase | 1 | 2002 | 70 | 0.050 |
Why?
| | G1 Phase | 1 | 2002 | 68 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 72 | 0.050 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2002 | 59 | 0.050 |
Why?
| | Nicotine | 1 | 2004 | 265 | 0.050 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2002 | 41 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 386 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 213 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 172 | 0.050 |
Why?
| | Quinazolines | 1 | 2022 | 243 | 0.040 |
Why?
| | Astrocytoma | 1 | 2020 | 108 | 0.040 |
Why?
| | Brain Stem Neoplasms | 1 | 2020 | 86 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 536 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 445 | 0.040 |
Why?
| | Lysine | 1 | 2020 | 242 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 49 | 0.040 |
Why?
| | Azepines | 1 | 2019 | 74 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2019 | 132 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2002 | 696 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1635 | 0.040 |
Why?
| | Triazoles | 1 | 2019 | 130 | 0.040 |
Why?
| | Pregnancy | 1 | 2008 | 5525 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2020 | 751 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1745 | 0.030 |
Why?
| | Transcription Factors | 1 | 2004 | 1528 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 521 | 0.030 |
Why?
| | Neural Stem Cells | 1 | 2016 | 115 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2020 | 1951 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 787 | 0.030 |
Why?
| | Dacarbazine | 1 | 2014 | 101 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2014 | 171 | 0.030 |
Why?
| | Tumor Burden | 1 | 2014 | 261 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2020 | 1699 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 316 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 157 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 445 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4086 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 399 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 3350 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1846 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1571 | 0.020 |
Why?
| | Dental Pulp | 1 | 2009 | 4 | 0.020 |
Why?
| | Alveolar Process | 1 | 2009 | 6 | 0.020 |
Why?
| | Tooth Root | 1 | 2009 | 13 | 0.020 |
Why?
| | Orthodontic Appliances | 1 | 2009 | 10 | 0.020 |
Why?
| | Receptor, trkA | 1 | 2009 | 16 | 0.020 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2009 | 31 | 0.020 |
Why?
| | Receptors, Growth Factor | 1 | 2009 | 49 | 0.020 |
Why?
| | Nerve Fibers | 1 | 2009 | 87 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 3334 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2374 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 335 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 9079 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2009 | 529 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2004 | 33 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2209 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2004 | 78 | 0.010 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2004 | 111 | 0.010 |
Why?
| | Rats | 1 | 2009 | 4943 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1103 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 2557 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 3890 | 0.010 |
Why?
| | Cytokines | 1 | 2004 | 1843 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 2812 | 0.010 |
Why?
|
|
Pierce's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|